A comprehensive mini-review published today after peer review in Brain Medicine by Dr. Tao Ma and colleagues at Wake Forest ...
One of the biggest challenges in treating Alzheimer's disease (AD) is how heterogeneous it is in terms of speed of decline and presence of other pathologies. That is, more than 50% of people with AD ...